To the Editor: Although acral melanoma has been widely evaluated, there is limited data available to analyze and compare clinical and survival data between nail unit melanoma and nonnail unit acral melanoma. [1] [2] [3] [4] One previous study demonstrated a peculiar spreading pattern of nail unit melanoma in association with complex anatomic structures of the nail unit. 5 The present study was designed to determine the spectrum of clinical features of acral melanoma.
Acral melanoma was classified according to tumor site and clinical characteristics, and the survival outcomes were analyzed. A retrospective review of the medical database revealed 213 cases of acral melanoma, of which 71 were cases of nail unit melanoma ( group A, Fig 1, A) , 25 were cases of digital melanoma ( group B, Fig 1, B) , and 117 were cases of melanoma on palms and soles ( group C, Fig 1, C ) that had been confirmed by skin biopsy during January 1996-December 2015.
All data is summarized in Table I . Breslow thickness was significantly deeper in group C (3.74 6 0.38 mm) compared with groups A (2.31 6 0.36 mm) and B (2.19 6 0.46 mm) (P ¼ .007, Table I ). Breslow thickness was not associated with stage of disease in group A (P ¼ .227, Table I ). The follow-up period of patients ranged 11-112 (median 61) months. There was no significant difference in overall survival (OS) among groups (Fig 1, D) . However, group A had a higher tendency to develop local recurrence compared with other groups; thus, progression-free survival (PFS) was significantly worse for group A (Fig 1, E ) . Group A had shorter PFS than group B (P ¼ .041) and group C (P ¼ .002). Local recurrence in group A was not associated with deeper Breslow thickness (P ¼ .839) or advanced stage (P ¼ .241, Supplemental Table I ; available at http://www.jaad. org). After adjusting for Breslow thickness, group A had a higher recurrence rate compared with other groups (odds ratio 1.59, 95% confidence interval 1.138-3.792, P ¼ .041).
There were differences in prognostic values of some clinical indexes such as amelanosis and local recurrence between nail unit melanoma and nonnail unit acral melanoma (Supplemental Table II , Supplemental Fig 1; available at http://www.jaad.org).
Although there was no significant difference in the frequency of advanced stage disease among subtypes, Breslow thickness was deeper in melanoma on palms and soles compared with other subtypes. Nail unit melanoma generally had a shallower Breslow thickness irrespective of disease stage. Breslow thickness was not associated with disease stage for nail unit melanoma. This finding suggests that Breslow thickness is not a good measure for disease progression in nail unit melanoma. The stage of disease in nail unit melanoma is dependent on the status of the lymph node (LN) or other viscera rather than the depth of the tumor.
Local recurrence rate was significantly higher for nail unit melanoma than nonnail unit acral melanoma, although the OS was similar, irrespective of tumor sites. Our study demonstrated that in contrast with melanoma on palms and soles, local recurrence of nail unit melanoma has no effect on survival if not accompanied by dissemination of disease to the LN or other viscera. It is unclear whether there are differences in the patterns of lesional spreading among the subtypes of acral melanoma.
Retrospective design is a limitation of this study. Treatment options have changed over the past several decades, but chronologic differences in treatments among melanoma patients were not reflected in our results. In conclusion, clinical and survival data suggest substantial heterogeneity among patients with acral melanoma, depending on the site of tumor development. Nail unit melanoma shows a distinct clinical course, including a higher recurrence rate, compared with nonnail unit acral melanoma. Two photographic approaches provide critical and complementary information in the differential diagnosis of malignant melanoma. Total body photography (TBP) traditionally provides baseline images from which macroscopic lesion changes can be detected, whereas digital epiluminescence (dermoscopic) microscopy reveals subtle changes in preexisting nevi. 2 Time and cost barriers restrict the use of both modalities to a select group of high-risk patients in pigmented skin lesion clinics.
Automation of TBP using a 25-camera array enables the routine capture of clinical images as an adjunct to a total body skin examination. Computer-assisted comparison of serial images exposes new and changed lesions, which are then photographed dermoscopically. 3 We describe the clinical, dermoscopic, and histopathologic features of melanomas #3 mm in size (micromelanomas) identified using this process.
We performed a retrospective study of 268 consecutive melanocytic lesions from which biopsy specimens were obtained from 218 patients between January 2015 and June 2016 in a single practice dermatology clinic. Lesion diameter was obtained from dermoscopic images taken before the biopsy specimens were obtained, and depth was obtained from pathology reports.
Eighty-one of 268 melanocytic lesions (30.22%) were melanoma in situ (MIS) or invasive melanoma (range 0.12-3.5; median 0.34), and 28 (34.57%) were #3 mm in diameter; 27 (33.33%) were [3 and #6 mm; and 26 (32.10%) were [6 mm. Of the lesions #3 mm, 21 (75.00%) were MIS and 7 (25.00%) were invasive (range 0.22-0.42; median 0.3 mm). Of lesions [3 and #6 mm, 13 (48.15%) were MIS and 14 (51.85%) were invasive (range 0.2-2.3; median 0.395 mm). Of lesions [6 mm, 16 (61.54%) were MIS and 10 (38.46%) were invasive (range 0.12-3.5; median 0.38 mm).
Nineteen of the 28 micromelanomas (68%) had diameters #2 mm and were sent for 2 additional blinded histopathologic assessments. Eleven of these (58%) were diagnosed as melanoma by all 3 dermatopathologists. The remaining 8 lesions were called melanoma by 1 pathologist and severely atypical by another with a comment that they could represent evolving melanoma and should be excised.
Time-lapse clinical images and the corresponding dermoscopic image of a melanoma can be seen in Fig 1. Dermoscopic features of chaos, clods, and amorphous areas were identified in all malignant lesions, but our sample size was not large enough to determine the relative value of each feature.
There are other reports of micromelanomas identified using various TBP and dermoscopy platforms with yields in the range of 23 (11%) of 206 lesions biopsied, 4 and 4 (4%) of 95 pigmented lesions biopsied. 5 Compared to the study by Abassi et al, 5 we found a significantly lower number needed to biopsy (3.1 vs 12.01), with a similar MIS: INV ratio (1.56:1) . These studies suggest that routine comparison of complete sets of TBP images combined with dermoscopy can identify very small lesions of melanoma, some of which are already invasive. .301
Group A: nail unit melanoma, Group B: digital melanoma, Group C: melanoma on palms and soles. AJCC, American Joint Committee on Cancer; CI, confidence interval; LN, lymph node; OS, overall survival; PFS, progression-free survival. *Statistically significant. y No data was found.
